Navigation Links
InventHelp Introduces Accessory to Allow for Dignified Concealment of Cancer Ports (DEG-125)
Date:12/31/2013

Pittsburgh, PA (PRWEB) December 31, 2013

"Three of my family members have cancer, and I noticed that my sister always tries to cover up her port with a regular adhesive bandage or clothing because of embarrassment," said an inventor from Omaha, Neb. "This inspired me to design the Port Aid."

This aesthetic, easy-to-use accessory provides a way to conceal a port area for both adult and child cancer patients. As a result, it avoids embarrassment, which promotes peace of mind and dignity. Producible in many design variations, the accessory is ideal for use in households, hospitals and cancer clinics.

The original design was submitted to the Des Moines office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 12-DEG-125, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

# # #

Read the full story at http://www.prweb.com/releases/InventHelp/Medical-Cancer-Port-Aid/prweb11421278.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Improved Method of Securing IV Lines Invented by InventHelp Client (BIR-2159)
2. Walker Invented for Children - Designed by InventHelp Client (LFY-453)
3. The Bath Buddy Ensures a Comfortable, Therapeutic Bath - Designed by InventHelp Client (BRK-508)
4. InventHelp Inventor Develops Infant Urine Collection Device (OCM-592)
5. Inventor and InventHelp Client Designs an Easier Way to Use a Cane (ORD-1837)
6. InventHelp Inventor Designs an Improved Sanitary Pad (PND-4272)
7. InventHelp Inventors Develop Improved Safety Belt (BGF-692)
8. InventHelp Inventor Develops Hemorrhoid Relief Kit (HTM-3000)
9. Inventors from InventHelp Develops Improved Hot/Cold Pack (AUP-327)
10. Innovative System for Self-Catheterization Invented by InventHelp Client (CMB-1794)
11. Affordable Eyewear Enhancement Invented by InventHelp Client (CMB-1795)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... announce the participation of high-level representatives from the Japan PMDA, US FDA, industry ... will address how CDISC standards help format data from clinical trials so that ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... Texas Veterinary Medical Association (TVMA) reminds pet owners that intervening at the first ... Heatstroke occurs when a pet’s normal body mechanisms cannot keep the body’s temperature ...
(Date:5/23/2016)... Hollywood, California (PRWEB) , ... May 23, 2016 ... ... Luciana Lagana specializes in research on discriminated minorities’ quality of life and ... this purpose, she is creating advocacy documentaries to be tested through research to ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... on its Chesterfield, Missouri, campus, Standard Process Inc. awarded $6,000 in ... Siewert and Chloe Tillman. Each student is in her fifth trimester of classes ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... to residents of Westchester County for over 24 years, recently hosted its sixth ... members joined HOW for two remembrance ceremonies, each concluding with the release of ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... Israel , May 19, 2016 ... the "Company"), an emerging global ophthalmic company focused on ... candidates which address ophthalmic conditions, announced today that it ... Italy ) for the manufacturing, distribution, marketing ... for the treatment of dry eye syndrome (DES) and ...
(Date:5/19/2016)... May 19, 2016 A ... World Biopsy Devices Market Opportunities and Forecasts, 2014 ... market generated $1,621 million in 2015. The MRI-guided ... and is expected to maintain this trend over ... http://photos.prnewswire.com/prnh/20140911/647229 ) , To know ...
(Date:5/19/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced ... of multiple cancer and hematological indications, will be presented ... titled " Clinical response in relapsed/refractory AML patients correlates ... a potent CXCR4 antagonist; results of a Phase 2a ... the European Hematology Association 21st Congress, to be held ...
Breaking Medicine Technology: